Figure 5
Figure 5. Reduction of Stat5 gene dosage impairs JAK2V617F-induced polycythemia in vivo. Hematocrit (A), reticulocyte counts (B), and leukocyte counts (C) from PB of recipients of BM from Stat5a/bfl/+ and Stat5a/bfl/− donors transduced with JAK2V617FMIGFP or MIGFPCre retrovirus analyzed on day 100 after transplantation. Hematocrit was significantly lower in the Stat5a/bfl/− JAK2V617FMIGFPCre group (P = .0114 vs Stat5a/bfl/− JAK2V617FMIGFP by t test).

Reduction of Stat5 gene dosage impairs JAK2V617F-induced polycythemia in vivo. Hematocrit (A), reticulocyte counts (B), and leukocyte counts (C) from PB of recipients of BM from Stat5a/bfl/+ and Stat5a/bfl/− donors transduced with JAK2V617FMIGFP or MIGFPCre retrovirus analyzed on day 100 after transplantation. Hematocrit was significantly lower in the Stat5a/bfl/−JAK2V617FMIGFPCre group (P = .0114 vs Stat5a/bfl/−JAK2V617FMIGFP by t test).

Close Modal

or Create an Account

Close Modal
Close Modal